UNSPSC 51171702: Loperamide

This classification denotes an opioid and antidiarrheal agent with the molecular formula C29H33ClN2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6X9OC3H4II, chemically known as 4-(4-chlorophenyl)-n,n-dimethyl-alpha,alpha-diphenyl-4-hydroxy-1-piperidinebutanamide but generally known as loperamide, which bears US NIH Compound Identifier 3955. European Medicines Agency schedules Loperamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08572MIG.

UNSPSC 51171702 Loperamide is a Commodity code representing a single active pharmaceutical ingredient (API) used in antidiarrheal medications. State and local governments procure loperamide-containing products through two distinct channels: as finished pharmaceutical products distributed via cooperative purchasing vehicles serving multiple state and local health systems, and as components within broader drug-testing and specimen-collection service contracts that require confirmation testing methodologies. The code sees activity from state health and human services commissions, county criminal justice departments, and multistate cooperative purchasing alliances coordinating acquisitions for corrections, public health, and employee health benefit programs.

Recent activity concentrates in Texas and Minnesota. The Texas Health and Human Services Commission posted RFI No. HHS0017013 on March 27, 2026 (response deadline April 3, 2026) to gather vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, seeking direct contracting models for self-insured plans and state agencies. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued RFP S1070000015802 on January 20, 2026 (due March 26, 2026) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products across participating state and local government facilities including Oregon. Collin County Community Supervision and Corrections Department (Texas) issued RFP 2026-327 on July 9, 2026 (due July 23, 2026) for offender specimen collection and drug testing services including immunoassay screening with confirmation testing via LC/MS/MS or GC/MS; the estimated contract value is $600,000 with a two-year term commencing September 1, 2026 and optional renewals through five years total. The anticipated award date for the Collin County RFP is August 10, 2026.